Fig. 2From: High score of LDH plus dNLR predicts poor survival in patients with HER2-positive advanced breast cancer treated with trastuzumab emtansineKaplan-Meier OS curves of HER2-Positive Advanced Breast Cancer Patients With T-DM1 Treatment. 2a Patients stratified according baseline LDH. 2b Patients stratified according baseline dNLR. 2c Patients stratified according LNIBack to article page